James Campbell – Managing Director & CEO Patrys is focused on the development of its deoxymab platform of cell-penetrating antibodies as therapies for a range of different cancers.
Views: 654
James Campbell – Managing Director & CEO Patrys is focused on the development of its deoxymab platform of cell-penetrating antibodies as therapies for a range of different cancers.